Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bluejay Diagnostics, Inc. (BJDX : NSDQ)

• Company Description    Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $1.62 Daily Weekly Monthly 20 Day Moving Average: 2,099,213 shares Shares Outstanding: 1.49 (millions) Market Capitalization: $2.42 (millions) Beta: 0.47 52 Week High: $37.50 52 Week Low: $1.46 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.99% -12.74% 12 Week -34.68% -42.76% Year To Date -66.74% -68.58%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MASSACHUSETTS AVENUE SUITE 203 - ACTON,MA 01720 USA ph: 844-327-7078 fax: - ir@bluejaydx.com https://bluejaydx.com

• General Corporate Information    Officers Neil Dey - Chief ExecutiveOfficer Douglas C. Wurth - Chairman Donald R. Chase - Director Fred S. Zeidman - Director Gary Gemignani - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 095633509 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 1.49 Most Recent Split Date: 11.00 (0.02:1) Beta: 0.47 Market Capitalization: $2.42 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.23 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 99.15% vs. Previous Quarter: 97.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -322.46 12/31/24 - -336.37 ROA 06/30/25 - - 03/31/25 - -262.96 12/31/24 - -270.68 Current Ratio 06/30/25 - - 03/31/25 - 2.71 12/31/24 - 6.05 Quick Ratio 06/30/25 - - 03/31/25 - 2.71 12/31/24 - 6.05 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 6.98 12/31/24 - 10.34 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©